These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24024535)

  • 41. Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients.
    Vulink NC; Denys D; Fluitman SB; Meinardi JC; Westenberg HG
    J Clin Psychiatry; 2009 Jul; 70(7):1001-8. PubMed ID: 19497245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late onset obsessive-compulsive disorder (OCD): A case report.
    Lozano-Vicario L; Fernández-Sotos P; Lozoya-Moreno S; Del Yerro-Álvarez MJ
    Actas Esp Psiquiatr; 2020 Jan; 48(1):36-46. PubMed ID: 32297650
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antidepressive agents in the treatment of obsessive-compulsive disorder].
    Hansen ES; Bolwig TG
    Ugeskr Laeger; 1997 Jan; 159(2):183-4. PubMed ID: 9012092
    [No Abstract]   [Full Text] [Related]  

  • 44. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
    Jacobsen FM
    J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Animal behavior case of the month. Congo African Grey parrot examined because of feather picking and self-injurious behavior.
    Juarbe-Díaz SV
    J Am Vet Med Assoc; 2000 May; 216(10):1562-4. PubMed ID: 10825940
    [No Abstract]   [Full Text] [Related]  

  • 46. Obsessive-compulsive disorders: a review of the literature.
    Salzman L; Thaler FH
    Am J Psychiatry; 1981 Mar; 138(3):286-96. PubMed ID: 6110343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.
    Nakaaki S; Murata Y; Furukawa TA
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):370. PubMed ID: 18588607
    [No Abstract]   [Full Text] [Related]  

  • 48. Anxiety disorders and obsessive compulsive disorder.
    Liebowitz MR
    Neuropsychobiology; 1998; 37(2):69-71. PubMed ID: 9566268
    [No Abstract]   [Full Text] [Related]  

  • 49. [Roadmap for therapeutic strategies of treatment resistant depression].
    El-Hage W
    Presse Med; 2016 Mar; 45(3):320-2. PubMed ID: 26970939
    [No Abstract]   [Full Text] [Related]  

  • 50. Silymarin treatment of obsessive-compulsive spectrum disorders.
    Grant JE; Odlaug BL
    J Clin Psychopharmacol; 2015 Jun; 35(3):340-2. PubMed ID: 25874918
    [No Abstract]   [Full Text] [Related]  

  • 51. Depression & Anxiety-SMi Conference. Shining light into dark corners. 12-13 May 2003, London, UK.
    Durrance A
    IDrugs; 2003 Jul; 6(7):664-7. PubMed ID: 12908452
    [No Abstract]   [Full Text] [Related]  

  • 52. Isoniazid-Induced Psychosis with Obsessive-Compulsive Symptoms (Schizo-Obsessive Disorder) in a Female Child.
    Baytunca MB; Erermis S; Bildik T; Kayahan B
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):819-20. PubMed ID: 25265091
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacotherapy of Obsessive-Compulsive Disorder During Breastfeeding.
    Uguz F
    Am J Ther; 2018; 25(5):e541-e547. PubMed ID: 27661749
    [No Abstract]   [Full Text] [Related]  

  • 54. The treatment of obsessional neurosis.
    Freed A; Kerr TA; Roth M
    Br J Psychiatry; 1972 May; 120(558):590-1. PubMed ID: 5041543
    [No Abstract]   [Full Text] [Related]  

  • 55. Aripiprazole in the Treatment of Obsessive Compulsive Disorder and Aggressive Behaviors in a Child With Prader Willi Syndrome: A Case Report.
    Akça ÖF; Yilmaz S
    J Clin Psychopharmacol; 2016 Oct; 36(5):526-8. PubMed ID: 27518476
    [No Abstract]   [Full Text] [Related]  

  • 56. Antidepressants in childhood attention deficit disorder and obsessive-compulsive disorder.
    Rapoport JL
    Psychosomatics; 1986 Nov; 27(11 Suppl):30-6. PubMed ID: 3797619
    [No Abstract]   [Full Text] [Related]  

  • 57. Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder.
    Adams TG; Bloch MH; Pittenger C
    J Clin Psychopharmacol; 2017 Apr; 37(2):269-271. PubMed ID: 28121735
    [No Abstract]   [Full Text] [Related]  

  • 58. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder.
    Coric V; Milanovic S; Wasylink S; Patel P; Malison R; Krystal JH
    Psychopharmacology (Berl); 2003 May; 167(2):219-20. PubMed ID: 12658528
    [No Abstract]   [Full Text] [Related]  

  • 59. Aripiprazole Monotherapy Was Effective in Treating Obsessive-Compulsive Disorder in a Preschool Boy.
    Coskun M
    J Clin Psychopharmacol; 2017 Oct; 37(5):636-637. PubMed ID: 28786825
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antidepressants for the treatment of obsessive-compulsive disorder].
    Pelissolo A
    Rev Prat; 2020 Sep; 70(7):799-800. PubMed ID: 33739733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.